Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
Palvella Therapeutics has raised $200.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2026.
Palvella Therapeutics's investors include Samsara BioCapital, Blue Owl, Adams Street Partners, BioAdvance, Ligand Pharmaceuticals.
Palvella Therapeutics is headquartered in Wayne, United States.
Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
Palvella Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Palvella Therapeutics — Funding & Investors." VCBacked, February 25, 2026, https://www.vcbacked.co/company/palvella-therapeutics. Accessed November 17, 2026.
VCBacked. (2026). Palvella Therapeutics — Funding & Investors. Retrieved November 17, 2026, from https://www.vcbacked.co/company/palvella-therapeutics
{{cite web |title=Palvella Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/palvella-therapeutics |website=VCBacked |access-date=November 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Palvella Therapeutics? Request a listing update